about
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea TreatmentsLangerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells.Effector and regulatory mechanisms in allergic contact dermatitis.T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays.Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells.Skin contact irritation conditions the development and severity of allergic contact dermatitis.Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis.Topical ivermectin improves allergic skin inflammation.Encapsulation of hydrophobic allergens into nanoparticles improves the in vitro immunological diagnosis of allergic contact dermatitis.Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.Characterization of Flucloxacillin-specific CD8+ T-cells in a mouse model.Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L.CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice.State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop.IL-1β induces thymic stromal lymphopoietin and an atopic dermatitis-like phenotype in reconstructed healthy human epidermis.Drug-induced aseptic meningitis: A possible T-cell-mediated hypersensitivity.Activation of Flucloxacillin-Specific CD8+ T-Cells With the Potential to Promote Hepatocyte Cytotoxicity in a Mouse Model.UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin.CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease.7th Drug hypersensitivity meeting: part two.A Perspective on the Interplay of Ultraviolet-Radiation, Skin Microbiome and Skin Resident Memory TCRαβ+ Cells.P11-05. Induction of CD8+ T cell mediated immune responses through skin and mucosa: identification of immunostimulatory versus tolerogenic dendritic cells.Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesionsDepletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergensWhich house-keeping genes for dendritic cell transcriptomic studies?[Allergic contact dermatitis: how to re-induce tolerance?]Skin exposure to weak and moderate contact allergens induces IFNgamma production by lymph node cells of CD4+ T-cell-depleted mice[Sensitisation versus tolerance in contact eczema][Epidemiology and pathophysiology of eczemas]The skin allergenic properties of chemicals may depend on contaminants--evidence from studies on coumarin[Epicutaneous testing of patients presenting atopic dermatitis: atopy patch tests]SLIT prevents the development of eczema in percutaneous allergen-sensitized miceCD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapyCurrent perspective of the etiopathogenesis of delayed-type, and T-cell-mediated drug-related skin diseasesLong-lasting allergic contact dermatitis to methylisothiazolinone misdiagnosed as atopic dermatitisInhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergyAutomatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients
P50
Q28072685-EF17BAFE-7A02-4C9E-9772-C1D937711322Q35913679-7CEB8771-317E-46AC-B2BD-0EAAC40F36F7Q37617470-108361BC-0710-4CBA-92FA-EF95A439D78CQ37780711-C4B82EAA-9CD9-4279-AFD3-9FC3A414A410Q38161481-F582CA28-1967-43B0-A66B-A717BE46E365Q38464149-A58E3C14-3194-449E-BFA8-77231A63A6CAQ38474290-EC677120-8406-4572-B659-FA6F60977C5BQ40385739-6A0F73CC-AFBB-41E1-8B29-2707A7389984Q41425576-26B0E8E5-2031-41DC-8A86-59548BA596FBQ42667819-3803146E-E6EC-4863-AB94-A97D530A2678Q46058066-4C996BC6-F6F3-4E2E-89AE-A511B4D43860Q46701571-4669A1F8-0A90-4C14-B1A2-7FDF0A90F3B9Q46926239-AF2B7CF1-58F6-453C-855A-DE3C83EC90CCQ47884985-D5391DBC-0066-4A00-9E33-E19F48BDDB0AQ48247956-E0B9E651-0934-42A8-92EB-227F7AF5F648Q50134738-F92B11A2-44D8-400A-89AB-4C3E1B13C2CEQ53223990-41444181-C1B7-4F1A-B334-D7EF4226BFBBQ53571005-9D22DD1A-6D00-4ACB-A676-A3F97C694B87Q53895280-98BD2314-6110-4E54-8FC2-EAB8605063FAQ54526061-685DA56A-2DB1-43FA-AF54-4CC3C35A7AF1Q55106781-583CFEA6-2569-4894-803C-3B995FC6490AQ55206202-3297E098-3B89-49B2-B97E-3A2E2D9AA872Q80178370-BE07D7F5-8C0E-4595-ABB0-767329267D17Q80651085-71296F05-B06B-4318-A0A8-5599304A784DQ80730761-F9BE839F-F9F8-4646-84F2-5A611B9DCBE3Q82466840-8E1EEC9B-06BA-4999-99BC-A7100C728F1DQ82588700-19F63371-7C4B-4D2E-AEDB-C5114A7A49D6Q82862470-F967ED1F-74D5-4F80-AD32-C1DC424ACADFQ83051910-96740FC6-45ED-4212-9D37-5761DD1F2E7DQ83310841-722466FD-7F34-4C03-8E83-0F391C7AD2D1Q84419136-922A0FD6-F254-4675-85F0-B86C3712EB4CQ84911251-195A0B75-C1EB-4149-99B7-42A9D4BEE8F8Q89506044-BFA86498-12D1-41F1-994D-FED302B16A6CQ89527829-636DDE7E-FEDA-43E4-84E8-3DB3BE8DE85FQ90363443-0262EB41-25F6-4A02-8579-60B685F76736Q91091626-621FB5DC-85F2-4163-B157-B61567F3AA7AQ91477480-AB6EE230-F071-48C7-9CF7-78943D1E92F6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marc Vocanson
@ast
Marc Vocanson
@en
Marc Vocanson
@es
Marc Vocanson
@nl
type
label
Marc Vocanson
@ast
Marc Vocanson
@en
Marc Vocanson
@es
Marc Vocanson
@nl
prefLabel
Marc Vocanson
@ast
Marc Vocanson
@en
Marc Vocanson
@es
Marc Vocanson
@nl
P106
P21
P31
P496
0000-0002-0181-8862